A detailed history of First Bancorp, Inc transactions in Amgen Inc stock. As of the latest transaction made, First Bancorp, Inc holds 702 shares of AMGN stock, worth $203,509. This represents 0.16% of its overall portfolio holdings.

Number of Shares
702
Previous 762 7.87%
Holding current value
$203,509
Previous $238,000 5.04%
% of portfolio
0.16%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$309.38 - $337.38 $18,562 - $20,242
-60 Reduced 7.87%
702 $226,000
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $537 - $649
2 Added 0.26%
762 $216,000
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $166,174 - $206,309
760 New
760 $204,000
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $185,514 - $235,718
810 New
810 $212,000
Q2 2022

Jul 14, 2022

SELL
$230.71 - $256.74 $194,719 - $216,688
-844 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $185,063 - $204,729
844 New
844 $204,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Bancorp, Inc Portfolio

Follow First Bancorp, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bancorp, Inc , based on Form 13F filings with the SEC.

News

Stay updated on First Bancorp, Inc with notifications on news.